Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yuichiro Nei"'
Autor:
Masahiro Nemoto, Yuichiro Nei, Brian Bartholmai, Kazuki Yoshida, Hiroki Matsui, Tamao Nakashita, Shinji Motojima, Masahiro Aoshima, Jay H. Ryu
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background Combined pulmonary fibrosis and emphysema (CPFE) is a heterogeneous clinico-radiological syndrome without a consensus definition. There are limited data on the relation between the amount of parenchymal fibrosis and prognosis. In
Externí odkaz:
https://doaj.org/article/c184467295e44510a043075554099a80
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186826 (2017)
Nontuberculous mycobacteria (NTM) lung disease is increasing globally. Although the etiological epidemiology of NTM is different across regions, Mycobacterium avium complex (MAC) is the leading cause of NTM lung disease in most countries, including m
Externí odkaz:
https://doaj.org/article/b657a18e6e9e43b884182e7eea684f54
Publikováno v:
Cureus.
Autor:
Masashi Kitani, Noriyuki Enomoto, Hiroaki Sugiura, Takafumi Suda, Yuichiro Nei, Tomoyuki Fujisawa, Tomoo Kishaba, Hironao Hozumi
Publikováno v:
Respiratory Investigation. 58:177-184
Background Acute exacerbation (AE) is a major cause of death in patients with idiopathic pulmonary fibrosis (IPF). Current evidence on AE-IPF has been largely based on clinical, rather than pathological, analyses. Methods We investigated AE incidence
Autor:
Masahiro Aoshima, Tamao Nakashita, Kazuki Yoshida, Hiroki Matsui, Shinji Motojima, Yuichiro Nei, Masahiro Nemoto, Jay H. Ryu, Brian J. Bartholmai
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)
Respiratory Research
Respiratory Research
Background Combined pulmonary fibrosis and emphysema (CPFE) is a heterogeneous clinico-radiological syndrome without a consensus definition. There are limited data on the relation between the amount of parenchymal fibrosis and prognosis. In this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e432f9f7a27799bd35e0e922b05abb1
https://doi.org/10.21203/rs.3.rs-41987/v1
https://doi.org/10.21203/rs.3.rs-41987/v1
Publikováno v:
The Eurasian Journal of Medicine. 50:6-10
Objective Idiopathic pulmonary fibrosis (IPF) is the most common parenchymal lung disease. Patients with IPF sometimes develop acute exacerbation (AE), which predicts a poor prognosis. To evaluate the predictors of 90-day mortality of AE in patients
Autor:
Tomoo Kishaba1 kishabatomoo@gmail.com, Yuichiro Nei1, Masashi Momose1, Hiroaki Nagano1, Shin Yamashiro1
Publikováno v:
Eurasian Journal of Medicine. 2018, Vol. 50 Issue 1, p6-10. 5p.
Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status
Publikováno v:
Journal of Thoracic Disease. 8:1112-1120
Idiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial pneumonias (IIPs) of unknown etiology that often affects male, elderly smokers. However, it is sometimes observed in never smokers. This study aimed to clarify the
Autor:
Hiroaki Nagano, Yuichiro Nei, Tomoo Kishaba, Rita L. McGill, Masashi Momose, kenta Nishiyama, Shin Yamashiro, Sachi Ibuki
Publikováno v:
The journal of medical investigation : JMI. 65(3.4)
BACKGROUND Dermatomyositis (DM) and polymyositis (PM) often have association with interstitial lung disease (ILD) which have disease specific autoantibody. METHODOLOGY We reviewed medical records of DM/PM associated ILD from January 2000 to December
Autor:
Akira Shiraki, Susumu Sato, Keisuke Tomii, Kazuma Nagata, Yuichiro Nei, Shinyu Izumi, Ryo Tachikawa, Michiko Hibi, Naoki Nishimura
Publikováno v:
Acute Critical Care.
Introduction: High-flow nasal cannula oxygen therapy (HFNC) provides higher oxygenation than standard oxygen therapy and more comfortable than non-invasive ventilation (NIV). Therefore, HFNC has been applied in adult patients with acute respiratory f